Discover in this France 3 TV report the collaboration between the CRCT team led by Dr. Pierre Cordelier and the Toulouse start-up Neovirtech: a therapeutic innovation opening up new perspectives in the treatment of cancer.
- IMLINFO / Cross-border Network of Personalized Immunotherapies for Non-Hodgkin’s Lymphomas
- Publication team 2 (J.S. Hoffmann) / ARTEMIS and XPF-ERCC1: 2 nucleases to prevent genetic instability
- Focus: collaboration between Pierre Cordelier’s team & Neovirtech on oncolitic viruses
- Focus: IMMUSPHINX program – Targeting sphingolipid metabolism to improve the efficacy of immunotherapies in melanoma
- Focus: Anti-TNF[alpha] antibodies improve immunotherapy in melanoma